Skip to main content
Clinical Trials/TCTR20200401001
TCTR20200401001
Enrolling By Invitation
Phase 4

A comparison of efficacy between combination use of methylergonovine intravenous slowly push plus oxytocin continuous infusion and carbetocin intravenous slowly push for prevent postpartum hemorrhage in cesarean section

one0 sites50 target enrollmentApril 1, 2020

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
postpartum hemorrhage &#44
Sponsor
one
Enrollment
50
Status
Enrolling By Invitation
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 1, 2020
End Date
June 30, 2020
Last Updated
last year
Study Type
Interventional
Sex
Female

Investigators

Sponsor
one

Eligibility Criteria

Inclusion Criteria

  • singleton pregnancy gestational age between 34\-42 weeks

Exclusion Criteria

  • pregnancy with
  • \- eclampsia or preeclampsia
  • \- hypertension
  • \- coagulation disorder
  • \- polycythemia
  • \- blood transfusion
  • \- ischemic heart disease
  • \- cerebrovascular disease
  • \- peripheral vascular disease
  • \- placenta previa

Outcomes

Primary Outcomes

Not specified

Similar Trials